These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21756754)

  • 1. [Predictors of Wingspan in-stent restenosis for the treatment of symptomatic intracranial arterial stenosis].
    Ma MM; Yin Q; Xu GL; Zhang RL; Zhu SG; Fan XY; Zhu WS; Liu XF
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(19):1303-7. PubMed ID: 21756754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management.
    Levy EI; Turk AS; Albuquerque FC; Niemann DB; Aagaard-Kienitz B; Pride L; Purdy P; Welch B; Woo H; Rasmussen PA; Hopkins LN; Masaryk TJ; McDougall CG; Fiorella DJ
    Neurosurgery; 2007 Sep; 61(3):644-50; discussion 650-1. PubMed ID: 17881980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiographic patterns of Wingspan in-stent restenosis.
    Albuquerque FC; Levy EI; Turk AS; Niemann DB; Aagaard-Kienitz B; Pride GL; Purdy PD; Welch BG; Woo HH; Rasmussen PA; Hopkins LN; Masaryk TJ; McDougall CG; Fiorella DJ
    Neurosurgery; 2008 Jul; 63(1):23-7; discussion 27-8. PubMed ID: 18728565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.
    Airoldi F; Briguori C; Iakovou I; Stankovic G; Biondi-Zoccai G; Carlino M; Chieffo A; Montorfano M; Cosgrave J; Michev I; Rogacka R; Sangiorgi GM; Colombo A
    Am J Cardiol; 2006 Apr; 97(8):1182-7. PubMed ID: 16616023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
    Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K
    J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term clinical and angiographic outcomes with the Wingspan stent for treatment of symptomatic 50-99% intracranial atherosclerosis: single center experience in 51 cases.
    Wolfe TJ; Fitzsimmons BF; Hussain SI; Lynch JR; Zaidat OO
    J Neurointerv Surg; 2009 Jul; 1(1):40-3. PubMed ID: 21994104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for in-stent restenosis after balloon-mounted stent placement for symptomatic intracranial atherosclerosis.
    Zhu SG; Zhang RL; Liu WH; Yin Q; Zhou ZM; Zhu WS; Zhu YL; Xu GL; Liu XF
    Eur J Vasc Endovasc Surg; 2010 Oct; 40(4):499-506. PubMed ID: 20554461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wingspan stenting for intracranial atherosclerotic stenosis: clinical outcomes and risk factors for in-stent restenosis.
    Shin YS; Kim BM; Suh SH; Jeon P; Kim DJ; Kim DI; Kim BS; Kim KH; Heo JH; Nam HS; Kim YD
    Neurosurgery; 2013 Apr; 72(4):596-604; discussion 604. PubMed ID: 23277374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic implications of in-stent restenosis located at the stent edge. Insights from the restenosis intra-stent balloon angioplasty versus elective stenting (RIBS) randomized trial.
    Alfonso F; Melgares R; Mainar V; Lezaún R; Vázquez N; Tascón J; Pomar F; Cequier A; Angel J; Pérez-Vizcayno MJ; Sabaté M; Bañuelos C; Fernández C; García JM;
    Eur Heart J; 2004 Oct; 25(20):1829-35. PubMed ID: 15474698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
    Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
    EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-stent restenosis after carotid angioplasty and stenting: a challenge for the vascular surgeon.
    Setacci C; de Donato G; Setacci F; Pieraccini M; Cappelli A; Trovato RA; Benevento D
    Eur J Vasc Endovasc Surg; 2005 Jun; 29(6):601-7. PubMed ID: 15878537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of patient age and stenosis location on wingspan in-stent restenosis.
    Turk AS; Levy EI; Albuquerque FC; Pride GL; Woo H; Welch BG; Niemann DB; Purdy PD; Aagaard-Kienitz B; Rasmussen PA; Hopkins LN; Masaryk TJ; McDougall CG; Fiorella D
    AJNR Am J Neuroradiol; 2008 Jan; 29(1):23-7. PubMed ID: 17989366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
    Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ;
    Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus-eluting stent versus balloon angioplasty for sirolimus-eluting stent restenosis: Insights from the j-Cypher Registry.
    Abe M; Kimura T; Morimoto T; Taniguchi T; Yamanaka F; Nakao K; Yagi N; Kokubu N; Kasahara Y; Kataoka Y; Otsuka Y; Kawamura A; Miyazaki S; Nakao K; Horiuchi K; Ito A; Hoshizaki H; Kawaguchi R; Setoguchi M; Inada T; Kishi K; Sakamoto H; Morioka N; Imai M; Shiomi H; Nonogi H; Mitsudo K;
    Circulation; 2010 Jul; 122(1):42-51. PubMed ID: 20566954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.
    Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes.
    Hong SJ; Kim MH; Ahn TH; Ahn YK; Bae JH; Shim WJ; Ro YM; Lim DS
    Heart; 2006 Aug; 92(8):1119-24. PubMed ID: 16449516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target lesion revascularization after wingspan: assessment of safety and durability.
    Fiorella DJ; Levy EI; Turk AS; Albuquerque FC; Pride GL; Woo HH; Welch BG; Niemann DB; Purdy PD; Aagaard-Kienitz B; Rasmussen PA; Hopkins LN; Masaryk TJ; McDougall CG
    Stroke; 2009 Jan; 40(1):106-10. PubMed ID: 18927447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of recurrent in-stent restenosis after beta-radiation: An analysis from the START 40/20 trial.
    Kaneda H; Honda Y; Morino Y; Lansky AJ; Yock PG; Bonan R; Fitzgerald PJ
    J Interv Cardiol; 2006 Oct; 19(5):376-80. PubMed ID: 17020560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Procedural success and 10-month outcome between Cypher and TAXUS drug-eluting stents for the treatment of in-stent restenosis].
    Chen JL; Yang YJ; Qiao SB; Yao M; Qin XW; Xu B; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):305-7. PubMed ID: 17711652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.